Abstract

Viral infections remain a major global health challenge, with limitations in conventional antiviral therapies 
including high costs, drug resistance, adverse side effects, and limited accessibility in resource-constrained regions. 
Beyond their established role in managing HIV, medicinal plants have emerged as promising sources of antiviral 
agents with broad-spectrum potential. This paper examines the antiviral properties of selected medicinal plants, 
including Echinacea, Elderberry, Garlic, Ginger, and Turmeric, highlighting their phytochemicals and 
mechanisms of action, such as viral entry inhibition, replication blockade, immune modulation, and synergistic 
activity with existing drugs. Evidence from laboratory studies, clinical evaluations, and ethnomedicinal practices 
underscores their effectiveness against influenza, herpes simplex virus, hepatitis C, coronaviruses, and other 
emerging pathogens. While challenges persist in terms of standardization, safety validation, dosage optimization, 
and regulatory approval, advancements in biotechnology and pharmacological research continue to strengthen the 
case for integrating phytomedicine into modern healthcare. Harnessing medicinal plants as cost-effective, 
sustainable, and culturally relevant alternatives offers a vital strategy for expanding the global antiviral arsenal 
beyond HIV.